RecruitingNot ApplicableNCT06880679
Ultrasound Acute Chest Syndrome Sickle Cell Disease
Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease
Sponsor
Indiana University
Enrollment
30 participants
Start Date
Apr 8, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Eligibility
Max Age: 25 Years
Inclusion Criteria3
- Age: 0-25 years old
- Diagnosis: Patients with a documented diagnosis of sickle cell disease (any genotype)
- Disposition: Hospitalized for a SCD-related complication (e.g. VOC)
Exclusion Criteria3
- Patient is considered hemodynamically unstable to undergo consent and study procedures
- Already has diagnosis of ACS prior to admission to inpatient unit
- POCUS operator not available
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPoint of Care Ultrasound
Point of Care Ultrasound during hospitalization
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06880679
Related Trials
The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease
NCT0697586553 locations
Sickle Cell, Pain and Mediterranean Diet
NCT068864771 location
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
NCT039378171 location
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)
NCT0692497032 locations
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
NCT071879733 locations